Table 4 Willingness of patients to participate in cancer clinical trials

From: Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives

Variable

Willingness for clinical trial (%)

P -value

Sex

  

 Male

163/233 (70.0)

0.023a

 Female

167/277(60.3)

 

Age (years)

  

30

8/12 (66.7)

0.381b

 30< to 40

36/59 (61.0)

 

 40< to 50

68/114 (59.6)

 

 50< to 60

87/125 (69.6)

 

 60< to 70

103/157 (65.6)

 

 <70

28/43 (65.1)

 

Line

  

 Neoadjuvant

14/25 (56.0)

0.003b

 Adjuvant

93/167 (55.7)

 

 Metastatic, first line

105/156 (67.3)

 

 Metastatic, second line

54/76 (71.1)

 

 Metastatic, third line

35/46 (76.1)

 

 Metastatic, fourth line

14/20 (70.0)

 

 Metastatic, fifth line

8/10 (80.0)

 

 Metastatic, sixth line

6/8 (75.0)

 

 Metastatic, seventh line

1/2 (50.0)

 

Marital status

  

 Single

22/34 (64.7)

0.886a

 Married

268/415 (64.6)

 

 Bereavement

20/29 (69.0)

 

 Divorced

13/18 (72.2)

 

Educational degree

  

 Postgraduate

24/36 (66.7)

0.775b

 University

95/152 (62.5)

 

 High school

119/179 (66.5)

 

 Middle school

35/53 (66.0)

 

 Elementary school

35/57 (61.4)

 

 Uneducated

8/10 (80.0)

 

Economic status

  

 >5c

38/61 (62.3)

0.887b

 5 to >4

31/46 (67.4)

 

 4 to >3

50/75 (66.7)

 

 3 to >2

39/58 (67.2)

 

 2 to >1

56/90 (62.2)

 

 1

83/125 (66.4)

 

Religion

  

 Buddhism

94/159 (59.1)

0.205a

 Christian

92/146 (63.0)

 

 Catholicism

53/73 (72.6)

 

 Others

53/78 (67.9)

 

Private cancer insurance

  

 Yes

152/243 (62.6)

0.392a

 No

163/246 (66.3)

 

Distance from clinic

  

2 h

226/337 (67.1)

0.120a

 >2 h

104/173 (60.1)

 

Awareness of clinical trial

  

 Yes

284/421 (67.5)

0.004a

 No

46/89 (51.7)

 
  1. aPearson χ2.
  2. bLinear-by-linear association.
  3. cThousands United States dollars per month.